Tech Transfer Roundup: How Johns Hopkins Optimizes Its Life Science Start-Ups
Executive Summary
The Baltimore university relies on an extensive infrastructure for tech transfer, and has a high volume of output to show for it. Recent tech transfer deals include Spark, Spotlight, Achilles, Biohaven, Cantabio and Renova, Zucara and Heat Biologics.
You may also be interested in...
Start-Up Quarterly Statistics, Q4 2016
A review of biopharma start-up dealmaking and financing from October through December 2016, based on data from Strategic Transactions.
Asia Deal Watch: Hansoh Teams Up With OliX On SIRNA Therapies
Among other Asia deals, Takeda adds to pair of recent gene therapy tie-ups with a CNS-focused cell therapy partnership with Immusoft; earlier it licensed ex-US rights to JCR’s Hunter syndrome drug.
Exelixis Moves Into RNA-Modifying Cancer Therapy With Storm Pact
Deal Snapshot: In addition to investigating the ADAR1 target with the UK biotech, Exelixis also has optioned a second candidate for non-Hodgkin’s lymphoma under its 2019 deal with Aurigene.